Vector BioMed Selected as Top Lentiviral Vector Design and Manufacturing Company

The Quick Take
Life Sciences Review recognizes the pure-play lentiviral vector company's work to help Asia-Pacific healthcare providers manufacture CAR-T therapies closer to patients. GAITHERSBURG, Md., Nov. 5, 2026 /PRNewswire/ -- Vector BioMed, a leading lentiviral vector supplier and contract vector...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Time-sensitive Networking Market worth $3.96 billion by 2032 - Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 5, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the global time-sensitive networking market is projected to grow from USD…
Business
GIL Investor Alert: Gildan Activewear Inc. Securities Class Action Notice - Contact SueWallSt
Gildan investors who bought before a June 2026 short report alleged roughly $500 million in pulled-forward sales may still seek recovery, even if they have…
Business
TENX Shareholder Alert: Tenax Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
Notice to Pension Funds, Asset Managers, and Fiduciaries: the lawsuit alleges Tenax overstated TNX-103's clinical prospects while raising $134 million, largely…
Business
QBTS Investor Alert: D-Wave Quantum Inc. Securities Class Action Notice - Contact SueWallSt
Market Impact: QBTS ended August 2026 at $17.51 after a flat quarterly revenue report and a CFO retirement announcement set off back-to-back sell-offs, as a…
